SINTX Technologies Inc
NASDAQ:SINT
SINTX Technologies Inc
Research & Development
SINTX Technologies Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SINTX Technologies Inc
NASDAQ:SINT
|
Research & Development
-$4.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Research & Development
-$251.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
SINTX Technologies Inc
Glance View
SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 36 full-time employees. The company went IPO on 2014-02-11. The firm is focused on manufacturing, research and development of silicon nitride ceramics for external partners. The firm's medical-grade silicon nitride products includes FleX SN-MC2, FleX SN-CSC, FleX SN-PEEK and FleX SN-AP, which are biocompatible, bioactive, antipathogenic and has a bone affinity. The firm's antipathogenic product, FleX SN-AP, which is a silicon nitride antipathogenic powder used in manufacturing of products such as face masks and personal protective equipment. The firm's non-medical applications are used in manufacturing of ceramic armors for the aerospace and defense industries. Its industrial silicon nitride has a combination of mechanical, thermal and electrical properties of any technical ceramic material.
See Also
What is SINTX Technologies Inc's Research & Development?
Research & Development
-4.3m
USD
Based on the financial report for Sep 30, 2025, SINTX Technologies Inc's Research & Development amounts to -4.3m USD.
What is SINTX Technologies Inc's Research & Development growth rate?
Research & Development CAGR 10Y
4%
Over the last year, the Research & Development growth was 31%. The average annual Research & Development growth rates for SINTX Technologies Inc have been 11% over the past three years , and 4% over the past ten years .
